Back to Agenda
Session 1: Strategy and Regulatory Science of Non-Clinical Development
Session Chair(s)
Chang Won Park
Deputy Director
NIFDS, Korea, Republic of
Speaker(s)
Strategy on Non-Clinical Development of CNS Drugs
Jung-Shin Park, PhD, RPh
SK Biopharmaceuticals, Korea, Republic of
Head of Drug Development Business Unit
Nonclinical Development Of Anticancer And Pediatric Drugs: A Regulatory Perspective
Yangmee Shin, PhD
KWiSE, United States
Sr. Pharmacologist
Have an account?
